KMC Speciality Hospitals (India) Ltd
₹ 89.0
-0.08%
17 Apr
- close price
About
Incorporated in 1982, KMC Speciality Hospitals (India) is in the healthcare sector running, operating, maintaining multi-specialty hospital in Trichy. The company belongs to the Kauvery Hospitals group. The Company is primarily engaged in the business of rendering medical and healthcare services.
Key Points
- Market Cap ₹ 1,452 Cr.
- Current Price ₹ 89.0
- High / Low ₹ 92.9 / 61.0
- Stock P/E 39.6
- Book Value ₹ 11.2
- Dividend Yield 0.00 %
- ROCE 17.4 %
- ROE 13.9 %
- Face Value ₹ 1.00
Pros
- Company is expected to give good quarter
- Company's median sales growth is 17.1% of last 10 years
Cons
- Stock is trading at 7.97 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 32 | 36 | 43 | 55 | 71 | 82 | 96 | 103 | 136 | 156 | 177 | 232 | 284 | |
| 30 | 31 | 35 | 42 | 56 | 66 | 75 | 79 | 99 | 114 | 129 | 174 | 207 | |
| Operating Profit | 2 | 6 | 8 | 12 | 14 | 16 | 21 | 23 | 37 | 42 | 48 | 57 | 77 |
| OPM % | 5% | 16% | 19% | 23% | 20% | 20% | 22% | 23% | 28% | 27% | 27% | 25% | 27% |
| 3 | 0 | 1 | 0 | 0 | 2 | 1 | 2 | 2 | 3 | 4 | 3 | 4 | |
| Interest | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 10 | 9 |
| Depreciation | 4 | 4 | 3 | 3 | 4 | 4 | 5 | 6 | 7 | 8 | 9 | 19 | 21 |
| Profit before tax | -2 | 0 | 4 | 8 | 10 | 12 | 17 | 18 | 32 | 36 | 41 | 32 | 52 |
| Tax % | -81% | 0% | 21% | 33% | 32% | 30% | 30% | 29% | 26% | 26% | 25% | 32% | |
| -0 | 0 | 3 | 5 | 7 | 9 | 12 | 13 | 24 | 27 | 30 | 21 | 37 | |
| EPS in Rs | -0.02 | 0.01 | 0.20 | 0.33 | 0.41 | 0.53 | 0.72 | 0.78 | 1.46 | 1.64 | 1.86 | 1.31 | 2.24 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 19% |
| 3 Years: | 19% |
| TTM: | 32% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 73% |
| 5 Years: | 13% |
| 3 Years: | -3% |
| TTM: | 53% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 32% |
| 3 Years: | 16% |
| 1 Year: | 30% |
| Return on Equity | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 22% |
| 3 Years: | 21% |
| Last Year: | 14% |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 |
| Reserves | -6 | -6 | -3 | 8 | 14 | 23 | 34 | 47 | 70 | 97 | 127 | 148 | 166 |
| 16 | 14 | 10 | 6 | 15 | 10 | 9 | 29 | 29 | 50 | 82 | 89 | 86 | |
| 7 | 7 | 6 | 8 | 8 | 10 | 11 | 13 | 13 | 18 | 38 | 32 | 31 | |
| Total Liabilities | 33 | 31 | 29 | 38 | 53 | 60 | 70 | 105 | 129 | 182 | 264 | 286 | 300 |
| 28 | 25 | 23 | 24 | 37 | 36 | 39 | 74 | 75 | 84 | 206 | 248 | 245 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 6 | 34 | 1 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 5 | 6 | 7 | 14 | 16 | 24 | 31 | 29 | 48 | 63 | 57 | 38 | 55 | |
| Total Assets | 33 | 31 | 29 | 38 | 53 | 60 | 70 | 105 | 129 | 182 | 264 | 286 | 300 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4 | 5 | 6 | 10 | 12 | 16 | 11 | 26 | 29 | 32 | 38 | 58 | |
| -2 | -1 | -1 | -4 | -19 | -9 | -8 | -43 | -29 | -48 | -56 | -51 | |
| -1 | -5 | -5 | -5 | 6 | -5 | -4 | 18 | -1 | 16 | 20 | -2 | |
| Net Cash Flow | 0 | -0 | -0 | 1 | -1 | 1 | -1 | 1 | -0 | 0 | 3 | 4 |
| Free Cash Flow | 2 | 5 | 5 | 6 | -3 | 13 | 7 | -15 | 16 | -12 | -37 | -6 |
| CFO/OP | 290% | 112% | 91% | 94% | 100% | 113% | 66% | 120% | 102% | 100% | 101% | 112% |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 11 | 12 | 13 | 12 | 13 | 8 | 8 | 9 | 10 | 10 | 9 | 9 |
| Inventory Days | 48 | 42 | 32 | 28 | 24 | 29 | 59 | 39 | 33 | 36 | 31 | 38 |
| Days Payable | 187 | 169 | 158 | 134 | 143 | 161 | 115 | 117 | 96 | 102 | 80 | 153 |
| Cash Conversion Cycle | -129 | -115 | -112 | -94 | -107 | -125 | -48 | -68 | -53 | -56 | -40 | -105 |
| Working Capital Days | -80 | -70 | -60 | -46 | -37 | -28 | -18 | -15 | -27 | -22 | -73 | -22 |
| ROCE % | 2% | 8% | 24% | 35% | 29% | 29% | 33% | 25% | 32% | 27% | 22% | 17% |
Insights
In beta| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| ALOS (Average Length of Stay) Days |
|
|||||||
| Blended ARPOB (Average Revenue Per Occupied Bed) INR |
||||||||
| Average Occupancy Rate Percentage |
||||||||
| Average Occupied Beds Number |
||||||||
| Census Beds Number |
||||||||
| In-Patient Volumes Number |
||||||||
| Out-Patient Volumes Number |
||||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
19h - Company confirms it is not a Large Corporate as of March 31, 2026.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
8 Apr - Copy of the certificate dated April 6, 2026 received from our RTA for the quarter ended March 31, 2026.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
28 Mar - Investor Presentation for the quarter and nine months ended December 31, 2025
-
Closure of Trading Window
27 Mar - Trading window closed from 01-Apr-2026 until 48 hours after audited results for year ending 31-Mar-2026.
-
Announcement under Regulation 30 (LODR)-Credit Rating
19 Mar - India Ratings upgraded KMC's long-term rating to IND AA- (Stable) from IND A+; INR768.15m term loan; March 18, 2026.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
Mar 2026TranscriptAI SummaryPPT
-
Nov 2025TranscriptAI SummaryPPT
-
Sep 2025TranscriptAI SummaryPPT
-
Jun 2025TranscriptAI SummaryPPT
-
Mar 2025TranscriptAI SummaryPPT
-
Dec 2024TranscriptAI SummaryPPT
-
Aug 2024TranscriptAI SummaryPPT
-
Jun 2024TranscriptAI SummaryPPT
-
Mar 2024TranscriptAI SummaryPPT
Part of Kauvery Group Hospitals:[1][2]
The company is a super-specialty hospital based in Trichy, belonging to the Kauvery Hospitals group. The group has 2250+ beds of multispecialty hospital chains at 12 locations, providing facilities for 1 lakh per year of IP patients and 10 lakhs per year of OP patients. The group is doing 600+ transplants, 1000+ Joint Replacements, and 1 lakh + Kidney procedures per year.